Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports
BMJ
.
2021 Nov 8:375:n2713.
doi: 10.1136/bmj.n2713.
Author
Elisabeth Mahase
1
Affiliation
1
The BMJ.
PMID:
34750163
DOI:
10.1136/bmj.n2713
No abstract available